Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.41 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9015844 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA | |
| SCHEMBL56398 | 1.00 | — | — | |
| SCHEMBL1470524 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA | |
| SCHEMBL730035 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA | |
| SCHEMBL12500356 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA | |
| SCHEMBL1470503 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA | |
| SCHEMBL1470569 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA | |
| SCHEMBL2873944 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA | |
| SCHEMBL514779 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA | |
| SCHEMBL2877322 | 1.00 | TSHR (0.50) | TSHRTHRBSMN1; SMN2HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1617 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748965-A2 | FORMULATIONS FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2026-05-27 | — | — | EP | claimed |
| EP-4743602-A1 | FORMULATIONS FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4744089-A1 | SELECTIVE DEPOSITION OF ALUMINUM-CONTAINING DIELECTRIC MATERIAL ON DIELECTRIC OVER METAL UTILIZING ALKYNES | Versum Materials US, LLC (US) | 2026-05-20 | — | — | EP | claimed |
| CN-117582797-B | Deep purification process for tail gas of calcium carbide furnace | 武汉科林化工集团有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260130860-A1 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | FLAGSHIP LABS 114, INC. (US) | 2026-05-14 | — | — | US | claimed |
| EP-4707426-A2 | HIGH-PURITY ALKYNES FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2026-03-11 | — | — | EP | claimed |
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-12503760-B2 | Methods of using high-purity alkynes for selective deposition | MERCK PATENT GMBH (DE) | 2025-12-23 | — | — | US | claimed |
| WO-2025226985-A1 | PASSIVATION OF POLYSILICON MATERIAL AND SELECTIVE DEPOSITION OF DIELECTRIC MATERIAL UTILIZING ALKYNES | VERSUM MATERIALS US, LLC (US) | 2025-10-30 | — | — | WO | claimed |
| CN-120124535-A | Multi-working condition simulation method for ecological environment change of reservoir construction | 山东省煤田地质规划勘察研究院 | 2025-06-10 | — | — | CN | claimed |
| WO-1997022558-A1 | OIL COAGULANT PRODUCTS AND METHODS OF USE THEREFOR | MANSFIELD & ALPER, INC. (US) | 1997-06-26 | — | — | WO | claimed |
| US-5581008-A | Branched organosilicon compounds and a method for their preparation | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 1996-12-03 | — | — | US | claimed |
| US-5545837-A | Organosilicon copolymers and methods for the preparation thereof | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 1996-08-13 | — | — | US | claimed |
| EP-0694573-A2 | Branched organosilicon compounds and a method for their preparation | Dow Corning Toray Silicone Company, Limited (JP) | 1996-01-31 | — | — | EP | claimed |
| EP-0683194-A1 | Organosilicon copolymers and methods for the preparation thereof | Dow Corning Toray Silicone Company, Limited (JP) | 1995-11-22 | — | — | EP | claimed |
| US-5442083-A | Method for the preparation of organosilicon polymer | DOW CORNING TORAY SILICONE COMPANY, LTD. (JP) | 1995-08-15 | — | — | US | claimed |
| US-5430179-A | Homogeneous process for the ruthenium catalyzed addition of carboxylic acids to alkynes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY (US) | 1995-07-04 | — | — | US | claimed |
| US-5310959-A | Reacting 1-decyne with 1,4-dihalo-2-butyne using a strong base and then reacting with 5-hexynoic acid; reacting with an amine in the presense of carbonyldiimidazole to amidate | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) | 1994-05-10 | — | — | US | claimed |
| US-4808340-A | Process for preparing methyl 4-oxo-5-tetradecynoate | NITTO ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1989-02-28 | — | — | US | claimed |
| US-4603185-A | Catalytic process for the polymerization of acetylene | THE STANDARD OIL COMPANY (US) | 1986-07-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12503760-B2 | Methods of using high-purity alkynes for selective deposition | ALK, ALKBH2, ALKBH3 | TSHR 4123/4885THRB 4781/4885SMN1; SMN2 918/4885 |
| US-20260130860-A1 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | NSUN3, NSUN2, LDLR | TSHR 545/4885THRB 753/4885SMN1; SMN2 803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.